Information  X 
Enter a valid email address

Company Name matching 'NuCana plc'

Date
Time Source
Company
Announcement
29 Aug 2019 1:00 pm GNW     NuCana plc NuCana to Present at the Morgan Stanley 17th Annual Global Healthcare Conference
27 Aug 2019 1:00 pm GNW     NuCana plc NuCana to Participate in Citi’s 14th Annual Biotech Conference
21 Aug 2019 9:01 pm GNW     NuCana plc NuCana Reports Second Quarter 2019 Financial Results and Provides Business Update
20 Aug 2019 1:00 pm GNW     NuCana plc Enrollment in the Independent Investigator-Sponsored Phase III Metastatic Pancreatic Study ACELARATE Has Been Suspended Following a Prespecified Futility Analysis
17 Jul 2019 12:00 pm GNW     NuCana plc NuCana Announces First Patients Dosed in Phase I Study of NUC-7738
13 Jun 2019 12:24 am GNW     NuCana plc NuCana Receives Orphan Drug Designation from the U.S. Food and Drug Administration for Acelarin® for the Treatment of Biliary Tract Cancer
30 May 2019 9:01 pm GNW     NuCana plc NuCana to Present at the Jefferies 2019 Healthcare Conference
14 May 2019 9:01 pm GNW     NuCana plc NuCana Reports First Quarter 2019 Financial Results and Provides Business Update
02 Apr 2019 1:00 pm GNW     NuCana plc NuCana to Participate in the William Blair 3rd Late-Stage Therapeutics Conference
07 Mar 2019 9:01 pm GNW     NuCana plc NuCana Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Business Update
05 Mar 2019 1:00 pm GNW     NuCana plc NuCana to Present at the Cowen and Company 39th Annual Health Care Conference
27 Feb 2019 9:45 pm GNW     NuCana plc NuCana to Present at the American Association for Cancer Research (AACR) Annual Meeting 2019
25 Jan 2019 1:15 pm GNW     NuCana plc NuCana plc Announces Withdrawal of Public Offering of ADSs
23 Jan 2019 9:01 pm GNW     NuCana plc NuCana plc Announces Proposed Public Offering of ADSs
28 Nov 2018 9:01 pm GNW     NuCana plc NuCana to Participate in Citi's 2018 Global Healthcare Conference
27 Nov 2018 9:01 pm GNW     NuCana plc NuCana Reports Third Quarter 2018 Financial Results and Provides Business Update
20 Nov 2018 12:00 pm GNW     NuCana plc NuCana to Participate in the 2018 Evercore ISI HealthCONx Conference
07 Nov 2018 12:00 pm GNW     NuCana plc NuCana to Participate in the Jefferies 2018 London Healthcare Conference
01 Nov 2018 11:00 am GNW     NuCana plc NuCana Announces First Patients Enrolled in Phase Ib Study of NUC-3373 in Advanced Colorectal Cancer
22 Oct 2018 12:00 pm GNW     NuCana plc NuCana Presents Data from Phase I Study of NUC-3373 at ESMO 2018
21 Oct 2018 11:54 am GNW     NuCana plc NuCana Reports Additional Promising Clinical Data on NUC-1031 (Acelarin®) as Front-Line Treatment of Advanced Biliary Tract Cancer at ESMO 2018
09 Oct 2018 6:15 pm GNW     NuCana plc NuCana to Present New Data from its ProTide Portfolio at the European Society for Medical Oncology (ESMO) 2018 Congress
29 Aug 2018 9:01 pm GNW     NuCana plc NuCana to Participate in Citi’s 13th Annual Biotech Conference
28 Aug 2018 9:01 pm GNW     NuCana plc NuCana Reports Second Quarter 2018 Financial Results and Provides Business Update
23 May 2018 9:01 pm GNW     NuCana plc NuCana Reports First Quarter 2018 Financial Results
21 May 2018 12:00 pm GNW     NuCana plc NuCana Announces Appointment of Cyrille Leperlier to its Board of Directors
09 Apr 2018 12:00 pm GNW     NuCana plc NuCana plc Announces Appointment of Adam George to its Board of Directors
21 Mar 2018 8:08 pm GNW     NuCana plc NuCana Reports Financial Results for the Year Ended December 31, 2017
02 Mar 2018 1:00 pm GNW     NuCana plc NuCana plc to Participate in the Cowen and Company 38th Annual Health Care Conference
19 Jan 2018 5:00 pm GNW     NuCana plc NuCana Announces Promising Clinical Data at ASCO GI on NUC-1031 (Acelarin®) as Front-Line Treatment of Advanced Biliary Tract Cancer
20 Nov 2017 1:00 pm GNW     NuCana plc NuCana plc to Participate in the Evercore ISI Biopharma Catalyst / Deep Dive Conference
15 Nov 2017 1:00 pm GNW     NuCana plc NuCana Announces First Patients Enrolled in Phase 2 Study of Acelarin in Platinum-Resistant Ovarian Cancer
02 Nov 2017 12:00 pm GNW     NuCana plc NuCana plc to Present at the Jefferies 2017 London Healthcare Conference
02 Oct 2017 7:27 pm GNW     NuCana plc NuCana plc Announces Closing of Initial Public Offering of ADSs and Exercise of Underwriters' Option to Purchase Additional ADSs


Company Announcements Archive »

 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t